Anti-Inflammatory Effects of Immunostimulation in Patients with COVID-19 Pneumonia

Anti-Inflammatory Effects of Immunostimulation in Patients with COVID-19 Pneumonia

Background: The effects of immunomodulators in patients with Coronavirus Disease 2019 (COVID-19) pneumonia are still unknown. We investigated the cellular inflammatory and molecular changes in response to standard-of-care + pidotimod (PDT) and explored the possible association with blood biomarkers...

Full description

Bibliographic Details
Main Authors: Pierachille Santus, Dejan Radovanovic, Micaela Garziano, Stefano Pini, Giuseppe Croce, Giuseppe Fuccia, Debora Spitaleri, Mara Biasin, Mario Clerici, Daria Trabattoni
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Journal of Clinical Medicine
Subjects:
COVID-19
viral pneumonia
immune response
pidotimod
immunomodulation
respiratory failure
Online Access:https://www.mdpi.com/2077-0383/10/24/5765

Internet

https://www.mdpi.com/2077-0383/10/24/5765

Similar Items